baber/WOPTO huggingface dataset:
Patent NZ-507006-A (NZ)
Title: Controlled release device for the preservation of wooden structure proximate soil where the controlled release device comprises a bound friable mixture in a polymeric matrix
Inventor: VAN VORIS PETER
IPC: A01N25/10
Filed: 1998-02-20
Abstract: A controlled release device for the prevention of the decay and deterioration of wooden objects caused by pests. The device, composed of polymers that incorporate pesticides, is placed proximate with the wood of the object to be protected. The pesticide is gradually released from the device and absorbed into the wood structure. The pesticide absorbed by the wood creates a barrier or an exclusion zone to penetration by insects. The controlled release device maintains a minimal effective level of pesticide in the barrier or exclusion zone for a predetermined period of time.
Patent NZ-508145-A (NZ)
Title: Use of chondrocytes for treating articulating joint surface cartilage using asurgical instrument having a handle with an undulating cutting surface
Inventor: IDOURAINE AHMED
IPC: A61F2/00
Filed: 1997-08-29
Abstract: A surgical instrument for sculpting a graft site having walls and a bottom within an articulating cartilage and/or surface. The instrument comprises a rod or handle and a cutting edge attached to the handle. The cutting edge is non-linear or undulating surface.
Patent NZ-509015-A (NZ)
Title: Transdermal therapeutic system containing oestradiol, norethisterone acetate, and crystallization inhibitors
Inventor: KLEIN ROBERT PETER
IPC: A61L15/58
Filed: 1999-06-08
Abstract: A transdermal therapeutic system in plaster form for controlled release of oestradiol in combination with norethisterone acetate, comprises a backing layer, a reservoir supersaturated with active ingredients containing oestradiol and norethisterone acetate and a detachable protective layer. The reservoir is attached to the backing layer and is prepared using polyacrylate pressure-sensitive adhesives and crystallization inhibitors. The crystallization inhibitor is an amino containing polymer.
Patent NZ-510024-A (NZ)
Title: Door opening and closing system
Inventor: FULLER GRAEME COLIN
IPC: H01F7/06
Filed: 1999-08-16
Abstract: A door state changing apparatus assists a user to move a door between a closed state where the door (8, 9) is positioned adjacent a door frame and an open state. The door state changing apparatus includes a permanent magnet (13, 14) provided on the door and having a permanent magnetic field. An electromagnet (11, 12) is located on the door frame adjacent the permanent magnet with the door in a closed state and is energisable to provide a magnetic field which reinforces the permanent magnetic field of the permanent magnet or to provide a magnetic field in opposition to the permanent magnetic field of the permanent magnet. A door position detector detects the open or closed state of the door and a user interface detects the presence of a user attempting to alter that state. A controller (6) receives input from the door position detector and the user interface and energises the electromagnet (11, 12) to provide a reinforcing magnetic field if a user is attempting to move the door (8, 9) from an open state to a closed state and provides an opposing magnetic field to the permanent magnetic field of the permanent magnet if the door is closed and the user interface indicates that a user is attempting to open the door. The disclosure is particularly adapted for use in a domestic refrigerator.
Patent NZ-511710-A (NZ)
Title: 4-Amino-azepan-3-one derivatives useful as protease inhibitors
Inventor: VEBER DANIEL FRANK
IPC: C07D413/14
Filed: 1999-12-21
Abstract: A 4-amino-azepane-3-one derivative or pharmaceutically acceptable salts, hydrates and solvates thereof has the formula (I) wherein: R1 is R4-N(R')-CH(R3)-C(O)-, R5-X-CH(R3)-C(O)- or CH2(R3)- C(O)-; R2 is H, alkyl, cycloalkyl-alkyl, Ar-alkyl, Het-alkyl, R9C(O)-, R9C(S)-, R9SO2-, R9OC(O)-, R9(R11)NSO2-, R9(R11)NC(O)-, R9(R11)NC(S)-, R7-N(R6)-CH(R8)-Z-, pyridyl- phenyl-CH2-CO- or pyridyl-phenyl-(CH2)2-; R3, R4, R' R6 to R9, R11 and R12 are as defined in the specification; R" is H, alkyl, Ar-alkyl, or Het-alkyl; R"' is H, alkyl, cycloalkyl-alkyl, Ar-alkyl or Het-alkyl and X is CH2, S, or O and Z is C (O) or CH2. The compound are useful in treating a disease characterized by bone loss such as osteoporosis, periodontitis or gingivitis or in treating a disease characterized by excessive cartilage or matrix degradation such as osteoarthritis or rheumatoid arthritis
Patent NZ-516524-A (NZ)
Title: A container for fuel system additive in two parts, relatively movable, to avoid spillage during transfer to vehicle fuel tank
Inventor: HUGHES BARNEY
IPC: B65D47/06
Filed: 2000-07-12
Abstract: A container is disclosed for a fuel system additive. The container comprises a sealable first part (1) for storing the fuel system additive and a second part (2) that is capable of opening a flap on a vehicle's fuel tank. The two parts are capable of relative movement which unseals the first part (1) so that the fuel system additive can leave the first part (1) and travel through the second part (2) into a vehicle's fuel tank. The container avoids or reduces spillage of the fuel system additive.
Patent NZ-520337-A (NZ)
Title: Method of and apparatus for applying visual indication means to a surface
Inventor: CHIRON PAUL JOSEPH
IPC: E01C23/16
Filed: 2001-02-09
Abstract: Dispensing apparatus (2) for dispensing reflective elements, such as glass beads (4), onto a surface, typically a road surface, the apparatus (2) being attached to a vehicle. The glass beads (4) are placed in an inlet means (6) and directed along a path around a drive means (10), which drive means (10) imparts a velocity to the glass beads for subsequent delivery onto the surface through an outlet means (20). The glass beads (4) exit the outlet means (20) at a velocity having substantially the same magnitude as the magnitude of velocity at which the vehicle travels and a direction substantially opposite to the direction of travel of the vehicle.
Patent NZ-523973-A (NZ)
Title: Gaming machine with wagering features
Inventor: OLIVE SCOTT
IPC: G06F19/00
Filed: 2003-02-04
Abstract: A gaming machine has a display means and a game controller arranged to control images of symbols on the display means. The game controller is arranged to play a game wherein one or more random events are caused to be displayed on the display means and, if a predefined winning event occurs, the machine awards a prize. When a trigger event occurs during the playing of a base game, a first feature is awarded that results in a feature prize potentially made up of a plurality of individual prizes. After completion of the first feature a second feature occurs that enables a player to wager the feature prize for at least one other prize, which is independent of a value of the feature prize.
Patent NZ-525859-A (NZ)
Title: Pharmaceutical composition comprising a molecular chaperonin 10 from Mycobacterium tuberculosis for treating an allergic condition or cancer
Inventor: COATES ANTHONY ROBERT MILNES
IPC: A61P17/02
Filed: 2001-11-16
Abstract: A pharmaceutical composition comprises a nucleic acid molecule comprising the nucleotide sequence of Figure 1, a sequence which has more than 66% identity to the sequence of Figure 1, a sequence that hybridizes to the sequence or a functionally equivalent fragment thereof or a polypeptide comprising the amino acid sequence of Figure 1 or a sequence that has more than 60% homology to the sequence of Figure 1 and provides a functionally equivalent protein. The composition can be used of the prevention or treatment of an allergic condition or cancer or for stimulating cytokine production. Preferably the conditions is selected from eczema, dermatitis, allergic rhinitis, allergic conjunctivitis, allergic airway diseases, hyper-eosinophilic syndrome, contact dermatitis, food allergy, and respiratory diseases characterized by eosinophilic airway inflammation and airway hyperresponsiveness, such as allergic asthma, intrinsic asthma, allergic bronchopulmonary aspergillosis, eosinophilic pneumonia, allergic bronchitis bronchiectasis, occupational asthma, reactive airway disease syndrome, interstitial lung disease, hypereosinophilic syndrome or parasitic lung disease.
Patent NZ-529883-A (NZ)
Title: Identification device for identifying rolling arti cles which are coded
Inventor: JOLLIFFE DAVID VICTOR
IPC: G06K17/00
Filed: 2002-06-14
Abstract: A tray ( 10 ) for supplying coded golf balls ( 50 ) to the tee ( 41 ) of a golf driving range comprises a first zone ( 11 ) for receiving golf balls, one of which is selected to be played by moving it by means of a club over a barrier ( 14 ) to a second ( 12 ) where it passes under gravity through an outlet ( 30 ) past a code reader ( 41 ) to the tee ( 41 ). An indicator light ( 46 ) is provided to confirm that the code has been read. The barrier ( 14 ) may have a grooved side ( 15 ) to assist transfer of the golf ball from the first zone ( 11 ) to the second zone ( 12 ).
Patent NZ-534438-A (NZ)
Title: Handle assembly, for power tool, housing motor, with rear handle aperture larger than a front handle aperture
Inventor: STONES KEVIN
IPC: H01H3/36
Filed: 2004-07-30
Abstract: The handle assembly has a rear handle 7 which defines an aperture larger than a corresponding aperture of a front handle 6. The handle assembly includes a housing which has a motor (not shown) and an output shaft caused to reciprocate by the motor. Typically the handle assembly forms part of a hedge trimmer.
Patent NZ-537873-A (NZ)
Title: Laryngoscope with multi-directional eyepiece
Inventor: CUBB ANTHONY
IPC: A61B1/267
Filed: 2003-03-14
Abstract: An endotracheal intubation device that enables indirect visualisation of a patient's airway from a 360 degree vantage point is disclosed. The intubation device has an optical assembly (13) encased by a housing (40). The optical assembly includes at least one optical fibre having a flexible distal portion (43) extending from a first end of the housing, and a gooseneck fibre conduit (58) extending from a second end of the housing. The housing contains a light source and a power source for the light. An eyepiece (47) with a lens system is positioned at the end of the gooseneck. A scabbard (10) receives a portion of the first end of the housing. The scabbard has a curved blade with a terminal edge surface and a number of spaced conduits. A first one of the conduits extends longitudinally through the scabbard and has a fluid impervious optically open end at the terminal edge. A second conduit extends along an outer surface of the scabbard and defines an opening sized to removably receive an endotracheal tube. A third conduit extends longitudinally through the scabbard and has two open ends, one of which opens onto the terminal edge.
Patent NZ-543197-A (NZ)
Title: An apparatus and method for furrow opening using a disc
Inventor: GREGOR DAVID
IPC: A01C5/06
Filed: 2004-09-20
Abstract: An apparatus (10) for furrow opening in soil including: a first disc (12) configured to rotate around a first axis of rotation, having a blade with an outer perimeter includes a plurality of symmetrical teeth (20); a second analogous disc (14) configured to rotate around a second axis of rotation, operatively coupled to the first disc; wherein the first and second discs are configured to incise and progressively widen a furrow in said soil thereby minimising soil disturbance.
Patent NZ-544713-A (NZ)
Title: Method of forming a canola protein isolate
Inventor: SCHWEIZER MARTIN
IPC: A23L25/00
Filed: 2004-06-21
Abstract: Disclosed is a method of forming a canola protein isolate having a protein content of at least about 90 wt% (N x 6.25) from intact canola seeds, including the separate steps of: (a) heat treating the intact canola oil seeds to deactivate enzymes therein, (b) dehulling the heat treated canola oil seeds, and (c) removing canola oil from the heat treated and dehulled oil seeds to provide a canola oil seed meal, and (d) processing the canola oil seed meal to recover therefrom the canola protein isolate.
Patent NZ-547387-A (NZ)
Title: A method of triggering an oxygen scavenger in a film by exposing it to a peroxide composition
Inventor: SPEER DREW V
Filed: 2006-05-23
Abstract: Disclosed herein is a method of triggering a film containing an oxygen scavenger, wherein the method comprises: (a) providing a composition comprising a peroxide; and (b) packaging the composition in a film comprising an oxygen scavenger; whereby the oxygen scavenger is triggered in the absence of ultraviolet light, heat, visible light, and electron beam radiation by exposure to the peroxide or an associated enriched oxygen environment. Particularly the oxygen scavenger comprises an organic oxygen scavenger, a transition metal catalyst, and a photoinitiator.
Patent NZ-549099-A (NZ)
Title: Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose
Inventor: JACOBS ALEXANDER THOMAS
IPC: A61M5/50
Filed: 2005-03-25
Abstract: A medication dispensing apparatus is disclosed. The medication dispensing apparatus has a drive member movable in a distal direction within a housing, and a fluid container with a piston advanceable by the drive member (60). The apparatus includes a latching element (180) having a skid (190) that is slidable along a surface of the drive member as the drive member passes distally during advancement. The drive member is arranged with the skid so as to maintain a latching lip of the latching element against a spring force in a first position free of the driving means during dose preparing and injecting prior to a final dose administration. The skid-engaging surface shifts distally of the skid such that the skid passes beyond a proximal end of that surface upon administration of a final dose, whereby the latching lip is urged by the spring force from the first position to a second position to physically lock the driving means to prevent further dose preparing and injecting.
Patent NZ-554510-A (NZ)
Title: Animal lead handle with plastic bag and sanitiser fluid dispensers
Inventor: VICKERS FRANK
Filed: 2007-04-13
Abstract: An animal lead handle device having a handle with a hand grip portion connected to a lead attachment portion. The hand grip portion has a first compartment to accommodate a sanitiser dispensing means and the lead attachment portion has a lead attachment means and a second compartment to accommodate a roll of plastics bags. The plastic bags are dispensed individually one at a time from the second compartment and the sanitiser dispensing means situated in the first compartment allows sanitiser to be dispensed to sanitise a user hands.
Patent NZ-555375-A (NZ)
Title: Noise reduction in liquid heating vessels
Inventor: SCOTT MICHAEL JAMES
Filed: 2007-05-24
Abstract: A liquid heating vessel, particularly for boiling water, with reduced noise is disclosed. A heater comprising a heater plate and an electric heating element attached to the underside of the plate forms at least a part of the base of the vessel. The heater surface (6) comprises a noise-reduction coating. A disrupter member (18) has a surface disposed above and extending over the upper surface of the heater plate opposite where the heating element is provided. The disrupter member is arranged to partially isolate a layer of liquid directly above the heating element.
Patent NZ-566129-A (NZ)
Title: Methods for freezing sorted sperm cells comprising a protein containing sperm cell extender and a protein free cryoprotectant before freezing
Inventor: SCHENK JOHN L
IPC: C12N5/076
Filed: 2006-07-24
Abstract: Disclosed is a method for freezing sorted sperm cells compromised by a sorting event comprising the steps of: subjecting a plurality of sperm cells to sorting stresses; selecting said plurality ofsperm cells for a desired characteristic; adding a protein-containing sperm cell extender to said plurality of selected sperm cells to form a first extended sperm cell mixture; cooling said first extended sperm cell mixture to create a first cooled extended sperm cell mixture; adding a protein-free cryoprotectant-containing sperm cell extender to said first cooled extended sperm cell mixture to form a second cooled extended sperm cell mixture; and freezing said second cooled extended sperm cell mixture.
Patent NZ-577774-A (NZ)
Title: Transmission of information using cyclically shifted sequences
Inventor: MALLADI DURGA PRASAD
IPC: H04L1/16
Filed: 2008-01-10
Abstract: A method for exchanging information in a wireless communication system and an apparatus for wireless communication are disclosed. The apparatus comprises means for using a first sequence for exchanging first information in a first time interval and means for using a second sequence for exchanging second information in a second time interval. The first sequence is modulated based on the first information to generate a first modulated sequence and the first modulated sequence is sent on a first subset of a plurality of subcarriers. The second sequence is a cyclic shift of the first sequence and is modulated based on the second information to generate a second modulated sequence. The second modulated sequence is sent on a second subset of a plurality of subcarriers. The base sequence is a constant amplitude zero auto correlation sequence.
Patent NZ-580707-A (NZ)
Title: Acylated cationic amino acids and uses thereof
Inventor: QUAY STEVEN C
IPC: C12N15/11
Filed: 2008-05-02
Abstract: A cationic lipid compound that comprises the structure: R3-(C=O)-Xaa-Z-R4. Xaa is norarginine or pyridylalanine; R3 is independently a substituted or unsubstituted C(6-22)alkyl or C96-22)alkenyl; R4 is independently a substituted or unsubstituted C(6-22)alkyl or C(6-22)alkenyl; Z is NH, O or an organic linker consisting of 1-40 atoms selected from hydrogen, carbon, oxygen, nitrogen and sulphur atoms. The compound can be used as a transfection agent by forming liposomes with nucleic acids. The compound can be used to deliver therapeutic nucleic acids, RNAi, dsRNA or mdRNA.
Patent NZ-581589-A (NZ)
Title: Solubilized sterile injectable formulation of docetaxel without Tween 80
Inventor: PALEPU NAGESWARA R
IPC: A61K31/337
Filed: 2008-06-19
Abstract: A sterile pharmaceutical formulation for use in treatment of a patient in need thereof is disclosed, which comprises:(a) docetaxel, or a pharmaceutically acceptable salt thereof, wherein the docetaxel or pharmaceutically acceptable salt thereof is in an amount of about mg/mL to about 20 mg/mL;(b) glycofurol or ethanol;(c) one or more hydrotropes comprising d-alpha-tocopheryl polyethylene glycol succinate (TPGS), polyethylene glycol (PEG), propylene glycol (PG), or a mixture thereof; and(d) water;wherein the formulation is substantially free of polysorbate surfactants and polyethoxylated castor oil; and wherein the formulation is precipitate-free at about six hours; andwherein the formulation may further comprise: (e) a buffer and (f) one or more antioxidants comprising alpha-lipoic acid.
Patent NZ-584097-A (NZ)
Title: Triggering random access channel procedure as a result of a comparison of stored and current buffer data
Inventor: ENGLUND EVA
IPC: H04L47/30
Filed: 2008-10-27
Abstract: Disclosed is a mobile terminal (700) capable of indicating a service request for resource allocation to a base station scheduler through a random access channel, RACH, procedure in a communication system. The mobile terminal is comprised of a processor unit (710) which includes a data transmit buffer that buffers data to be transmitted in the communication system and a comparator that compares present buffer content status to the status of the stored latest transmitted buffer content. The mobile terminal (700) also includes a service request triggering mechanism that sends a single bit message on a random access channel to the scheduler, triggering the scheduler to assign uplink resources for data transmission, when a change in buffer status is detected at said comparison. The mobile terminal (700) further includes a memory unit (720) used to store the latest terminal buffer status data transmission and a communication interface (730).
Patent NZ-591344-A (NZ)
Title: Stabilized pharmaceutical composition comprising a nonpeptidic active agent
Inventor: HIRAISHI YASUHIRO
IPC: A61K47/38
Filed: 2009-07-27
Abstract: A stabilized pharmaceutical composition comprising a nonpeptidic pharmaceutically active ingredient having a primary or secondary amino group, an excipient and an acidic compound as stabilizer, wherein the nonpeptidic pharmaceutically active ingredient is a compound represented by the formula depicted herein, and the variables shown in the formula are as defined in the specification; wherein the excipient is selected from the group consisting of mannitol, croscarmellose sodium, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyethylene glycol, polyvinylpyrrolidone, crystalline cellulose, lactose, sucrose, starch, cornstarch, titanium oxide (TiO2) and light anhydrous silicic acid; and wherein the acidic compound is an organic acid selected from the group consisting of adipic acid, ascorbic acid, benzoic acid, oleic acid, succinic acid, acetic acid, tartaric acid, sorbic acid, fumaric acid, lactic acid, maleic acid, malonic acid, citric acid, malic acid and a salt thereof.
Patent NZ-592998-A (NZ)
Title: Depot formulation comprising oxtreotide and two linear polylactide-co-glycolide polymers (PLGAs)
Inventor: AHLHEIM MARKUS
IPC: A61K47/38
Filed: 2009-12-14
Abstract: 592998 Disclosed herein is a depot formulation comprising as active ingredient octreotide, or a pharmaceutically acceptable salt thereof, and two linear polylactide-co-glycolide polymers (PLGAs) and having a molar lactide:glycolide (L:G) ratio of 75:25 and different inherent viscosities; and the use thereof for the treatment of a disease selected from long-term maintenance therapy in acromegalic patients, and treatment of severe diarrhoea and flushing associated with malignant carcinoid tumours and vasoactive intestinal peptide tumours (vipoma tumours). In one embodiment wherein said polymers have different inherent viscosities between 0.8 and 0.1 dL/g in CHCl3. In one embodiment wherein said two polymers have different end groups, particularly wherein one polymer has an ester and the other polymer has an acid end group.
Patent NZ-593379-A (NZ)
Title: Accelerator mixture and method of use
Inventor: KOLOMIETS ELENA
IPC: C04B22/06
Filed: 2009-12-03
Abstract: 593379 Disclosed is a concrete or mortar accelerator mixture which is present as a powder or a liquid, and which contains the following: (a) aluminium in oxidation state 3, (b) sulphate, and (c) hexafluorosilicic acid. Also disclosed is the process of making the accelerator, the hardening layer produced by the accelerator, a concrete or mortar comprising the accelerator and the use of hexafluorosilicic acid as a stabilizer for concrete or mortar accelerator mixtures.
Patent NZ-596337-A (NZ)
Title: Plastic bottle
Inventor: FONTANA CAROLINE
IPC: B65D1/02
Filed: 2010-07-12
Abstract: A light weight flat container such as a bottle (20) formed of an elastically deformable plastic material and having a staged load bearing system including primary and secondary load bearing surfaces. The bottle includes two opposing wide sides (21, 22) and two opposing narrow sides (25, 26) on which the load bearing surfaces may be disposed. A base (27) is provided which protrudes beyond the narrow sides (25, 26) in some embodiments. During processing of the bottles on a conveyor fill line, mating primary load bearing surfaces (30, 30') on adjacent bottles initially engage and begin to deform under contact forces. The mating secondary load bearing surfaces (32, 32') next engage to better distribute the contact forces and control deformation of the bottles to below the elastic limit of the plastic material to avoid plastic deformation or crazing damage to the bottles when the contact forces subsides. A bottle processing method is also provided.